News Headlines

Display #
Title
FDA approves drug to treat Parkinson's disease
Novartis heart drug serelaxin fails study
Biogen’s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target
UCSF Heart Doctor Wary of Amgen-Paid Repatha Study
Novartis' Cosentyx is first and only IL-17A inhibitor to potentially modify the course of psoriasis
Search finds no studies yet on whether Zika mosquitoes could sometimes transmit HIV, reports Dr. Leslie Norins
Romania bids to host EU drug agency after Brexit
Merck must face renewed Fosamax warning claims
Pharmacist guilty of racketeering in deadly U.S. meningitis outbreak
Alzheimer's disease linked to the metabolism of unsaturated fats
Bayer's Rivaroxaban demonstrated superior protection against recurrent venous thromboembolism compared with Aspirin in EINSTEIN CHOICE study
New 'gene silencer' drug reduce cholesterol by over 50 percent
New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes
eyeforpharma Philadelphia 2017: Be the trusted healthcare partner #efpPhilly
Breast cancer drug combo succeeds key study
Med Ad News Announces 2017 Manny Awards Finalists, Person of the Year
Republicans revamp U.S. health bill, boost benefits to older Americans
Hospitals have lower death rates during surprise inspections
Republicans revamp Obamacare bill
First patient cured of rare blood disorder
Heat Biologics Rockets as Lung Cancer Med Hits Mid-Stage Goals
Merck Accelerator hits new peak of applications
Facebook Hiring Dozens for Secretive Division, Rumored to be Working on Brain-Scanning Technology and Other Med Device
Sanofi Announces Results of First-of-Its-Kind Social Experiment Revealing Real-Life Impact of Symptoms on Allergy Sufferers in the U.S.
Esperion Hits A New High After Positive Feedback For Its Heart Drug From The FDA
Harvoni Study: 97% of Hep C Patients Cured
Dietary anti-cancer compound may work by influence on cellular genetics
Human antibody for Zika virus promising for treatment, prevention
AstraZeneca and Circassia enter strategic collaboration in respiratory disease
FDA Deals Another Blow to AstraZeneca’s Blood Drug